Next Generation Diabetes Therapy and Drug Delivery Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
Next Generation Diabetes Therapy and Drug Delivery Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global next generation diabetes therapy and drug delivery market is expected to grow at a CAGR of around 14.9% during 2024-2033. This report on global next generation diabetes therapy and drug delivery market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global next generation diabetes therapy and drug delivery market by segmenting the market based on product type, demographic, indication, end user, and region. Also, detailed profiles of companies operating in the next generation diabetes therapy and drug delivery market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Rise in the Healthcare Expenditure • Increase in the Disposable Income Among the Diabetic Patients
Market Challenges
• Lack of Awareness • Less Variability in Products
Historical & Forecast Period
Base Year: 2023 Historical Period: 2019-2023 Forecast Period: 2024-2033
• Adult Population (>14 Years) • Child Population (14 Years)
Market by Indication
• Type 1 Diabetes • Type 2 Diabetes
Market by End User
• Clinics • Intensive Care Units (ICUs) • Home Healthcare
Market by Region
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran United Arab Emirates Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Next Generation Diabetes Therapy and Drug Delivery Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Next Generation Diabetes Therapy and Drug Delivery Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type
5.1. Introduction
5.2. Inhalable Insulin
5.3. Oral Insulin
5.4. Insulin Patches
5.5. Continuous Glucose Monitoring Systems
5.6. Artificial Pancreas
6. Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic
6.1. Introduction
6.2. Adult Population (>14 Years)
6.3. Child Population (14 Years)
7. Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication
7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes
8. Global Next Generation Diabetes Therapy and Drug Delivery Market by End User
8.1. Introduction
8.2. Clinics
8.3. Intensive Care Units (ICUs)
8.4. Home Healthcare
9. Global Next Generation Diabetes Therapy and Drug Delivery Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. Abbott laboratories
13.2.2. Dexcom, Inc
13.2.3. Eli Lilly and Company
13.2.4. Glysens Incorporated
13.2.5. Johnson & Johnson
13.2.6. MannKind Corporation
13.2.7. Medtronic plc
13.2.8. Novo Nordisk A/S
13.2.9. Sanofi S.A.
13.2.10. Senseonics Holdings, Inc.
List of Figures
Figure 1: Global Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 2: Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, 2023
Figure 3: Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic, 2023
Figure 4: Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication, 2023
Figure 5: Global Next Generation Diabetes Therapy and Drug Delivery Market by End User, 2023
Figure 6: Global Next Generation Diabetes Therapy and Drug Delivery Market by Region, 2023
Figure 7: Global Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 8: Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (in %), 2023 & 2033
Figure 9: Global Inhalable Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 10: Global Inhalable Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 11: Global Oral Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 12: Global Oral Insulin Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 13: Global Insulin Patches Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 14: Global Insulin Patches Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 15: Global Continuous Glucose Monitoring Systems Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 16: Global Continuous Glucose Monitoring Systems Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 17: Global Artificial Pancreas Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 18: Global Artificial Pancreas Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 19: Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic (in %), 2023 & 2033
Figure 20: Global Adult Population (>14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 21: Global Adult Population (>14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 22: Global Child Population (14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 23: Global Child Population (14 Years) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 24: Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication (in %), 2023 & 2033
Figure 25: Global Type 1 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 26: Global Type 1 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 27: Global Type 2 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 28: Global Type 2 Diabetes Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 29: Global Next Generation Diabetes Therapy and Drug Delivery Market by End User (in %), 2023 & 2033
Figure 30: Global Clinics Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 31: Global Clinics Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 32: Global Intensive Care Units (ICUs) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 33: Global Intensive Care Units (ICUs) Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 34: Global Home Healthcare Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 35: Global Home Healthcare Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 36: Global Next Generation Diabetes Therapy and Drug Delivery Market by Region (in %), 2023 & 2033
Figure 37: Europe Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 38: Europe Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 39: Europe Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2023 & 2033
Figure 40: Germany Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 41: United Kingdom Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 42: France Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 43: Italy Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 44: Spain Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 45: Russia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 46: Netherlands Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 47: North America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 48: North America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 49: North America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2023 & 2033
Figure 50: United States Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 51: Canada Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 52: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 53: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 54: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2023 & 2033
Figure 55: China Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 56: Japan Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 57: India Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 58: South Korea Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 59: Australia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 60: Indonesia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 61: Latin America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 62: Latin America Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 63: Latin America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2023 & 2033
Figure 64: Mexico Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 65: Brazil Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 66: Argentina Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 67: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2023
Figure 68: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2024-2033
Figure 69: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market by Country (in %), 2023 & 2033
Figure 70: Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 71: Turkey Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 72: Iran Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 73: UAE Next Generation Diabetes Therapy and Drug Delivery Market (in US$ Million), 2019-2033
Figure 74: Market Value Chain
List of Tables
Table 1: Global Next Generation Diabetes Therapy and Drug Delivery Market Portraiture
Table 2: Global Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (in US$ Million), 2023 & 2033
Table 3: Global Next Generation Diabetes Therapy and Drug Delivery Market by Demographic (in US$ Million), 2023 & 2033
Table 4: Global Next Generation Diabetes Therapy and Drug Delivery Market by Indication (in US$ Million), 2023 & 2033
Table 5: Global Next Generation Diabetes Therapy and Drug Delivery Market by End User (in US$ Million), 2023 & 2033
Table 6: Global Next Generation Diabetes Therapy and Drug Delivery Market by Region (in US$ Million), 2023 & 2033
Table 7: Europe Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2023 & 2033
Table 8: North America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2023 & 2033
Table 9: Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2023 & 2033
Table 10: Latin America Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million), 2023 & 2033
Table 11: Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market by Country (in US$ Million),